Conclusions Combined examination of telomerase activity and serum CA(subscript 125) is helpful for early diagnosis, serving as a disease monitor of ovarian cancer.

• 结论：端粒酶活性检测联合血清CA（下标125）检测有助于卵巢肿瘤的早期诊断病情监测。